85 related articles for article (PubMed ID: 5337285)
1. Symposium on immunosuppressive drugs. Effect of cancer chemotherapeutic agents on normal tissues in man.
Frei E
Fed Proc; 1967; 26(3):918-24. PubMed ID: 5337285
[No Abstract] [Full Text] [Related]
2. Symposium on immunosuppressive drugs. Variable influences of antitumor drugs and progestational agents on immune responses in rodents.
Haines RF; Johnson AG; Petering HG
Fed Proc; 1967; 26(3):934-43. PubMed ID: 5337287
[No Abstract] [Full Text] [Related]
3. [Effect of cytostatic drugs on the immunological reactivity of the body].
Liashenko VA
Vestn Akad Med Nauk SSSR; 1965; 20(7):72-9. PubMed ID: 5323634
[No Abstract] [Full Text] [Related]
4. Are immunosuppressive anticancer drugs self-defeating?
Schwartz RS
Cancer Res; 1968 Jul; 28(7):1452-4. PubMed ID: 5665993
[No Abstract] [Full Text] [Related]
5. Symposium on immunosuppressive drugs. Late effects of immunosuppressive anticancer drugs.
Karnofsky DA
Fed Proc; 1967; 26(3):925-33. PubMed ID: 5337286
[No Abstract] [Full Text] [Related]
6. Inhibition of the primary immune response in man by anti-metabolites.
Hersh EM; Carbone PP; Wong VG; Freireich EJ
Cancer Res; 1965 Aug; 25(7):997-1001. PubMed ID: 5843275
[No Abstract] [Full Text] [Related]
7. [Enhancement and inhibition of the damaging function of immunolymphocytes by cytostatic drugs in vitro tissue].
Petrányi GG; Benczur M; Onody K; Alföldy P; Institoris L
Orv Hetil; 1974 Mar; 115(10):572-3. PubMed ID: 4815826
[No Abstract] [Full Text] [Related]
8. The expression of TRAIL and its receptors in gastric cancer and the apoptotic effect of rh-TRAIL on SGC7901 cells.
Hu JK; Yang K; Li CM; Zhang B; Chen ZX; Chen XZ; Chen JP
Oncol Rep; 2009 Mar; 21(3):681-8. PubMed ID: 19212626
[TBL] [Abstract][Full Text] [Related]
9. Review of the potential effects of three commonly used antineoplastic and immunosuppressive drugs (cyclophosphamide, azathioprine, doxorubicin on the embryo and placenta).
Matalon ST; Ornoy A; Lishner M
Reprod Toxicol; 2004; 18(2):219-30. PubMed ID: 15019720
[No Abstract] [Full Text] [Related]
10. Symposium on immunosuppressive drugs. Immunosuppressive drugs. II.
Schwartz R
Fed Proc; 1967; 26(3):914-7. PubMed ID: 5337284
[No Abstract] [Full Text] [Related]
11. [On the relationship between chemotherapy and immunity].
Nigro N
Minerva Pediatr; 1968 Oct; 20(41):2119-21. PubMed ID: 5746685
[No Abstract] [Full Text] [Related]
12. Effect of combination of deoxypyridoxine with known anti-proliferative or immunosuppressive agents on lymphocyte serine hydroxymethyltransferase.
Trakatellis A; Dimitriadou A; Exindari M; Christodoulou D; Malissiovas N; Antoniadis A; Haitoglou K
Postgrad Med J; 1994; 70 Suppl 1():S89-92. PubMed ID: 7526359
[TBL] [Abstract][Full Text] [Related]
13. Immunosuppressive effects of cytostatic diastereomeric dibromhexitols.
Petrányi G; Nouza K; Szollár J; Institoris L
Folia Biol (Praha); 1969; 15(5):366-76. PubMed ID: 5344439
[No Abstract] [Full Text] [Related]
14. Symposium on immunosuppressive drugs. Some biochemical effects of alkylating agents.
Wheeler GP
Fed Proc; 1967; 26(3):885-92. PubMed ID: 5337282
[No Abstract] [Full Text] [Related]
15. [Experimental research on the influence of some antiblastics on production of agglutinating and hemolyzing antibodies].
Giaquinto M; Falagario M
Attual Ostet Ginecol; 1965; 11(3):330-42. PubMed ID: 5834503
[No Abstract] [Full Text] [Related]
16. Methoxy-9-ellipticine lactate. I. Experimental study (oncostatic and immunosuppressive actions; preclinical pharmacology).
Le Men J; Hayat M; Mathé G; Guillon JC; Chenu E; Humblot M; Masson Y
Rev Eur Etud Clin Biol; 1970 May; 15(5):534-8. PubMed ID: 5430156
[No Abstract] [Full Text] [Related]
17. Symposium on immunosuppressive drugs. Other clinical considerations.
Murray JE; Austen KF
Fed Proc; 1967; 26(3):953-7. PubMed ID: 5337289
[No Abstract] [Full Text] [Related]
18. Increased immunogenicity of drug-resistent L 1210 leukemias in CDF1 mice.
Nicolin A; Vadlamudi S; Goldin A
Arch Ital Patol Clin Tumori; 1970; 13(3):125-33. PubMed ID: 5521381
[No Abstract] [Full Text] [Related]
19. Screening system for the evaluation of preparations with potential cytostatic and immunotropic activity. III. Derivatives of hexahydrochromate.
Giełdanowski J; Steuden W
Arch Immunol Ther Exp (Warsz); 1981; 29(2):267-71. PubMed ID: 7305636
[TBL] [Abstract][Full Text] [Related]
20. Symposium on immunosuppressive drugs. Biochemistry and pharmacology of purine analogues.
Elion GB
Fed Proc; 1967; 26(3):898-904. PubMed ID: 5337283
[No Abstract] [Full Text] [Related]
[Next] [New Search]
